Eli Lilly, Boehringer Ingelheim’s Jardiance clinches heart failure edge with FDA nod for wider label

Eli Lilly, Boehringer Ingelheim’s Jardiance clinches heart failure edge with FDA nod for wider label
fkansteiner
Thu, 02/24/2022 – 14:11